TCD Pharma

About:

TCD Pharma is a biotechnology company engaged in the discovery, development and commercialization of oncology drugs.

Website: http://www.tcdpharma.com

Twitter/X: TCD_Pharma

Top Investors: CRB Inverbío, Clave Mayor, S.G.E.C.R.

Description:

Chosen as one of Spain’s top 5 biotech investment opportunities, TCD is focused on creating the future of Oncology by developing innovative therapies that address unmet medical needs. Established in 2005 and with one product, TCD-717, already in clinical trials the Company is positioning itself as Spain’s Partner of Choice for Oncology drug discovery and development opportunities. TCD’s strong management team, its strategy of building its pipeline through in-licensing and partnerships and by leveraging resources through collaborations and outsourcing via premier Contract Research Organizations, allows TCD to be in the forefront of Oncology drug development while significantly lowering risks and costs.

Total Funding Amount:

$10.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Madrid, Madrid, Spain

Founded Date:

2005-01-01

Contact Email:

info(AT)tcdpharma.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2012-01-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai